Literature DB >> 20387115

Correlation between cathepsin D serum concentration and carotid intima-media thickness in hemodialysis patients.

Seyed Adel Moallem1, Fatemeh Nazemian, Sepideh Eliasi, Seyed Ali Alamdaran, Jamal Shamsara, Amir Hooshang Mohammadpour.   

Abstract

AIM: Cardiovascular (CV) disease is the leading cause of death in hemodialysis (HD) patients, and approximately half of mortalities in HD patients are attributed to CV disease. Atherosclerosis is the most frequent cause of CV complications in patients with end-stage renal disease (ESRD). Based on recent studies, cathepsin D has been suggested as a potential marker of atherosclerosis, and we hypothesized that there is an association between serum concentration of cathepsin D and carotid intima-media thickness (CIMT) in hemodialysis patients.
METHODS: Thirty-one hemodialysis patients (18 men and 13 women) were enrolled in this study. Serum levels of soluble cathepsin D were measured with an enzyme-linked immunosorbant assay (ELISA) kit. CIMT was determined in each patient.
RESULTS: The data showed that there was a positive significant correlation between serum concentration of cathepsin D and CIMT by using Pearson correlation (P value <0.05).
CONCLUSION: Based on the results of this study, cathepsin D could be suggested to have a role in the development of atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20387115     DOI: 10.1007/s11255-010-9729-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  31 in total

Review 1.  Arterial remodeling. Mechanisms and clinical implications.

Authors:  M R Ward; G Pasterkamp; A C Yeung; C Borst
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

2.  Progression of atherosclerosis in hemodialysis patients: effect of adiponectin on carotid intima media thickness.

Authors:  Megumi Tsushima; Yuriko Terayama; Akishi Momose; Tomihisa Funyu; Chikara Ohyama
Journal:  J Atheroscler Thromb       Date:  2008-08       Impact factor: 4.928

3.  High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia.

Authors:  T Kawagishi; Y Nishizawa; T Konishi; K Kawasaki; M Emoto; T Shoji; T Tabata; T Inoue; H Morii
Journal:  Kidney Int       Date:  1995-09       Impact factor: 10.612

Review 4.  Atherosclerotic plaque rupture: local or systemic process?

Authors:  Esther Lutgens; Robert-Jan van Suylen; Birgit C Faber; Marion J Gijbels; Petra M Eurlings; Ann-Pascale Bijnens; Kitty B Cleutjens; Sylvia Heeneman; Mat J A P Daemen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-09-25       Impact factor: 8.311

5.  Atherosclerosis in hemodialysis patients: traditional and nontraditional risk factors.

Authors:  Sebastijan Bevc; Radovan Hojs; Robert Ekart; Tanja Hojs-Fabjan
Journal:  Acta Dermatovenerol Alp Pannonica Adriat       Date:  2006-12

6.  Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions.

Authors:  Jukka K Hakala; Riina Oksjoki; Petri Laine; Hong Du; Gregory A Grabowski; Petri T Kovanen; Markku O Pentikäinen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-15       Impact factor: 8.311

7.  Carotid intima-media thickness as a cardiovascular risk marker in pediatric end-stage renal disease patients on dialysis and in renal transplantation.

Authors:  A Delucchi; H Dinamarca; H Gainza; C Whitttle; I Torrealba; G Iñiguez
Journal:  Transplant Proc       Date:  2008-06-30       Impact factor: 1.066

Review 8.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

Review 9.  Cathepsin D--many functions of one aspartic protease.

Authors:  Petr Benes; Vaclav Vetvicka; Martin Fusek
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-08       Impact factor: 6.312

10.  Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Sofia Jormsjö; Dirk M Wuttge; Allan Sirsjö; Carl Whatling; Anders Hamsten; Sten Stemme; Per Eriksson
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

View more
  10 in total

1.  Myocardial Upregulation of Cathepsin D by Ischemic Heart Disease Promotes Autophagic Flux and Protects Against Cardiac Remodeling and Heart Failure.

Authors:  Penglong Wu; Xun Yuan; Faqian Li; Jianhua Zhang; Wei Zhu; Meng Wei; Jingbo Li; Xuejun Wang
Journal:  Circ Heart Fail       Date:  2017-07-10       Impact factor: 8.790

2.  Plasma cathepsin D levels: a novel tool to predict pediatric hepatic inflammation.

Authors:  Sofie M A Walenbergh; Tom Houben; Tim Hendrikx; Mike L J Jeurissen; Patrick J van Gorp; Anita C E Vreugdenhil; Marlou P Adriaanse; Wim A Buurman; Marten H Hofker; Antonella Mosca; Patrick J Lindsey; Anna Alisi; Daniela Liccardo; Nadia Panera; Ger H Koek; Valerio Nobili; Ronit Shiri-Sverdlov
Journal:  Am J Gastroenterol       Date:  2015-03-03       Impact factor: 10.864

3.  Investigation of the Relationship between Cardiovascular Biomarkers and Brachial-Ankle Pulse Wave Velocity in Hemodialysis Patients.

Authors:  Ping-Ruey Chou; Pei-Yu Wu; Ping-Hsun Wu; Teng-Hui Huang; Jiun-Chi Huang; Szu-Chia Chen; Su-Chu Lee; Mei-Chuan Kuo; Yi-Wen Chiu; Ya-Ling Hsu; Jer-Ming Chang; Shang-Jyh Hwang
Journal:  J Pers Med       Date:  2022-04-15

4.  Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention.

Authors:  Sofie M A Walenbergh; Tom Houben; Sander S Rensen; Veerle Bieghs; Tim Hendrikx; Patrick J van Gorp; Yvonne Oligschlaeger; Mike L J Jeurissen; Marion J J Gijbels; Wim A Buurman; Anita C E Vreugdenhil; Jan Willem M Greve; Jogchum Plat; Marten H Hofker; Satish Kalhan; Jussi Pihlajamäki; Patrick Lindsey; Ger H Koek; Ronit Shiri-Sverdlov
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

Review 5.  The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease.

Authors:  Pasquale Cocchiaro; Valeria De Pasquale; Rossella Della Morte; Simona Tafuri; Luigi Avallone; Anne Pizard; Anna Moles; Luigi Michele Pavone
Journal:  Front Cell Dev Biol       Date:  2017-12-19

6.  Evaluation of serum cathepsin D concentrations in coronary artery disease.

Authors:  Amir Hooshang Mohammadpour; Zakieh Salehinejad; Sepideh Elyasi; Mohsen Mouhebati; Seyed Reza Mirhafez; Sara Samadi; Majid Ghayour-Mobarhan; Gordon Ferns; Amirhossein Sahebkar
Journal:  Indian Heart J       Date:  2018-01-08

7.  Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague⁻Dawley Rats .

Authors:  Princy Khurana; Tulasi Yadati; Sandeep Goyal; Atul Dolas; Tom Houben; Yvonne Oligschlaeger; Anil K Agarwal; Aditya Kulkarni; Ronit Shiri-Sverdlov
Journal:  Biomolecules       Date:  2019-05-04

8.  Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH Mice.

Authors:  Tulasi Yadati; Tom Houben; Albert Bitorina; Yvonne Oligschlaeger; Marion J Gijbels; Ronny Mohren; Dieter Lütjohann; Princy Khurana; Sandeep Goyal; Aditya Kulkarni; Jan Theys; Berta Cillero-Pastor; Ronit Shiri-Sverdlov
Journal:  Front Immunol       Date:  2021-07-16       Impact factor: 7.561

9.  Increased Cathepsin D Correlates with Clinical Parameters in Newly Diagnosed Type 2 Diabetes.

Authors:  Lei Liu; Baoxian Chen; Xudong Zhang; Lun Tan; Dao Wen Wang
Journal:  Dis Markers       Date:  2017-12-10       Impact factor: 3.434

10.  The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach.

Authors:  Martijn F Hoes; Jasper Tromp; Wouter Ouwerkerk; Nils Bomer; Silke U Oberdorf-Maass; Nilesh J Samani; Leong L Ng; Chim C Lang; Pim van der Harst; Hans Hillege; Stefan D Anker; Marco Metra; Dirk J van Veldhuisen; Adriaan A Voors; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2019-12-03       Impact factor: 15.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.